Recursion Pharmaceuticals
RXRX
#5297
Rank
C$2.18 B
Marketcap
C$3.51
Share price
-9.93%
Change (1 day)
-40.26%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2026 (TTM): -C$0.68 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are C$67.01 Million. In 2025 the company made an earning of -C$0.93 Billion a decrease over its 2024 earnings that were of -C$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.68 Billion-27.12%
2025 -C$0.93 Billion38.83%
2024 -C$0.67 Billion39.51%
2023 -C$0.48 Billion38.68%
2022 -C$0.35 Billion30.46%
2021 -C$0.27 Billion114.28%
2020 -C$0.13 Billion